Recruiting
Hyperparathyroidism secondary
RecruitingPhase 3 Evaluation of Etelcalcetide for Secondary Hyperparathyroidism in Pediatric Patients with Chronic Kidney Disease on Hemodialysis
Registered drugNo placebo
Phase 3 Evaluation of Etelcalcetide for Secondary Hyperparathyroidism in Pediatric Patients with Chronic Kidney Disease on Hemodialysis
Registered drugNo placebo
- Disease:Hyperparathyroidism secondary
- Substances:Etelcalcetide
Countries:
Belgium
Belgium- Participants:0–17 years
- Substances:Etelcalcetide



